CD14 and cancer: To test the hypothesis that the S100A9+ MDSC-derived macrophages can protect cancer cells from EGFR-TKI killing, we isolated CD14+ monocytes from PBMCs and induce them into macrophages (monocytes-derived macrophages, MDMs).